Psygen Labs
- Company typePrivate
- Founded2019
- HeadquartersCalgary, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Psygen Labs firmographics
Firmographics- Name
- Psygen Labs
- Legal name
- Psygen Industries Ltd.
- Website
- https://psygen.ca
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Psygen Labs industry classification
Industry- Product category
- Pharmaceutical CDMO / Psychedelic API Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
- akta.pro secondary industries
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
Keywords
Where Psygen Labs is headquartered
LocationHeadquarters
- HQ city
- Calgary
- HQ country
- Canada
- HQ region
- North America
Markets served
Psygen Labs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing Services: B2B contract development and manufacturing services for pharmaceutical companies and research organizations requiring early-stage development and clinical manufacturing of psychedelic and neuroplastogen APIs. Revenue is generated through project-based contracts with pharmaceutical clients.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Psygen Labs product offering
Product offeringCore offering
Psygen Labs is a Canadian Contract Development and Manufacturing Organization (CDMO) that manufactures psychedelic and neuroplastogen Active Pharmaceutical Ingredients (APIs) such as LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA for clinical research and pharmaceutical development. The company offers integrated CMC (Chemistry, Manufacturing and Controls) services spanning Process Research & Development, Phase I–III API Production, and Technology Transfer under GMP-aligned conditions.
Product overview
Psygen is a Contract Development and Manufacturing Organization (CDMO) operating under 'The Psychedelic CDMO™' brand. It is the only company solely focused on manufacturing psychedelic and neuroplastogen APIs. The company offers an integrated CMC (Chemistry, Manufacturing, and Controls) services platform comprising Process R&D, Phase I-III API Production, and Technology Transfer. Psygen manufactures six primary psychedelic APIs: LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA, serving clinical and scientific research clients globally.
Differentiator
Problem solved
Functional benefit
Products and services
- Psychedelic Active Pharmaceutical Ingredients (APIs) Pharmaceutical-grade active ingredients including LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA, produced under GMP-aligned conditions for use by pharmaceutical companies and clinical researchers developing psychedelic-based therapeutics.
- CMC Services (Chemistry, Manufacturing and Controls) Integrated contract development offering comprising Process Research & Development, Phase I–III API Production, and Technology Transfer, designed for pharmaceutical companies and clinical-stage drug developers needing support across the psychedelic API development lifecycle.
- Process Research & Development Contracted laboratory research to develop and optimize synthetic routes and processes for psychedelic APIs prior to scale-up manufacturing, targeted at pharmaceutical clients progressing candidates toward clinical trials.
- Phase I–III API Production Small- to mid-scale production of psychedelic APIs to supply Phase I, II, and III clinical trials, available to pharmaceutical companies and research organizations advancing psychedelic-based therapeutics.
- Technology Transfer Services Transfer of manufacturing processes and documentation to clients or their designated manufacturers to enable scale-up and commercial production, supporting pharmaceutical partners moving from clinical to commercial supply.
Companies that use Psygen Labs
Customer profileSegments1 record
Ideal customer profiles2 records
Psygen Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Psygen Labs partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Canadian Healthcare System (via Special Access Program)supportingPsygen Labs participates in Canada's Special Access Program by donating psychedelic medications to physicians. This is not a formal partnership but rather a regulatory participation program allowing access to restricted medications for medical purposes.
Recent moves7 records
Expansion highlights4 records
Psygen Labs competitors and assessment
Company assessmentBroad incumbents
- Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher's pharma services segment, is a top-tier global CDMO offering API and drug product development/manufacturing. Comparable to Psygen as a contract API manufacturer for pharmaceutical clients, but at vastly greater scale and across many therapeutic areas.
- Lonza Group: Lonza is a leading global CDMO for small molecules, biologics, and cell/gene therapies. Comparable to Psygen in providing GMP API and process development services, but operates at much larger scale and across multiple modalities.
- Catalent: Catalent is one of the largest global CDMOs providing formulation, clinical and commercial manufacturing for oral, sterile, and biologic dosage forms. Comparable to Psygen in providing GMP contract manufacturing, but operates across a far broader therapeutic and dosage-form portfolio.
- WuXi AppTec / WuXi STA: WuXi STA is one of the largest global API CDMOs, offering process R&D and GMP manufacturing of small-molecule APIs. Comparable to Psygen in providing small-molecule API CDMO services for clinical-stage programs, but at dramatically larger scale and broader scope.
- PCI Pharma Services: PCI Pharma Services is a global CDMO providing clinical and commercial supply, packaging, and manufacturing services. Comparable to Psygen as a contract service provider to pharma clients across clinical phases, but with broader packaging and commercial supply capabilities.
Direct peers
- Avid Bioservices: Avid Bioservices is a mid-sized CDMO focused on biologics process development, GMP manufacturing, and analytical services. Comparable to Psygen as a mid-sized CDMO with concentrated focus on a specialized manufacturing segment and project-based B2B client engagements.
- Halo Pharma (Bora Pharmaceuticals): Halo Pharma, now part of Bora Pharmaceuticals, is a CDMO offering oral solid dose and specialty drug product development and manufacturing. Comparable to Psygen as a smaller specialty CDMO serving mid-sized pharma with project-based contract manufacturing engagements.
- Alcami Corporation: Alcami is a U.S.-based specialty CDMO offering API development, analytical services, and drug product manufacturing for small and mid-sized pharma clients. Comparable to Psygen as a focused CDMO serving niche/specialty pharmaceutical pipelines with custom development and manufacturing.
- Contract Pharmaceuticals Limited (CPL): CPL is a specialty CDMO focused on liquid and semi-solid pharmaceutical development and manufacturing. Comparable to Psygen as a focused, mid-sized CDMO providing specialized contract manufacturing services for niche therapeutic and clinical-stage programs.
- Pyramid Laboratories: Pyramid Laboratories is a smaller specialty CDMO offering aseptic fill-finish, analytical, and small-batch GMP manufacturing. Comparable to Psygen as a boutique CDMO serving niche/specialty pharmaceutical pipelines with focused manufacturing capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Psygen Labs social profiles
Digital presencePsygen Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Psygen Labs leadership team
Management profileNumber of profiles
Profiles8 records
Psygen Labs funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Psygen Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Psygen Labs
What does Psygen Labs do?
Psygen Labs is a Canadian Contract Development and Manufacturing Organization (CDMO) that manufactures psychedelic and neuroplastogen Active Pharmaceutical Ingredients (APIs) such as LSD, DMT, 5-MeO-DMT, Ibogaine, Psilocybin, and MDMA for clinical research and pharmaceutical development. The company offers integrated CMC (Chemistry, Manufacturing and Controls) services spanning Process Research & Development, Phase I–III API Production, and Technology Transfer under GMP-aligned conditions.
Is Psygen Labs a public or private company?
Psygen Labs is a private company. It is classified as venture growth investor backed and is currently operating.
When was Psygen Labs founded?
Psygen Labs was founded in 2019. It employs 11 to 50 people.
Where is Psygen Labs based?
Psygen Labs is headquartered in Calgary, Canada, in the North America region.
How does Psygen Labs make money?
One revenue line is on record: contract Manufacturing Services.
Who are Psygen Labs's main competitors?
Broad incumbents on record are Patheon (Thermo Fisher Scientific), Lonza Group, Catalent, WuXi AppTec / WuXi STA and PCI Pharma Services. Direct peers are Avid Bioservices, Halo Pharma (Bora Pharmaceuticals), Alcami Corporation, Contract Pharmaceuticals Limited (CPL) and Pyramid Laboratories.
Does Psygen Labs have an API?
No public API is recorded for Psygen Labs.
What industry is Psygen Labs in?
Psygen Labs's product category is Pharmaceutical CDMO / Psychedelic API Manufacturing. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 3254 and its SIC code is 2834.